Home/Filings/4/0001358403-17-000171
4//SEC Filing

Musso Alan A 4

Accession 0001358403-17-000171

CIK 0001358403other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 4:05 PM ET

Size

5.3 KB

Accession

0001358403-17-000171

Insider Transaction Report

Form 4
Period: 2017-12-11
Musso Alan A
CFO and Treasurer
Transactions
  • Sale

    Common Stock

    2017-12-11$9.33/sh17,117$159,66731,585 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on June 7, 2017.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.13 to $9.52. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth above.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001295830

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:05 PM ET
Size
5.3 KB